Evidence map›Paper›PMID 39502102›Full record

ArticleCanadian oncology nursing journal = Revue canadienne de nursing oncologique2024

Effectiveness of an intervention (effleurage and petrissage) on the severity of chemotherapy-induced peripheral neuropathy (CIPN) among patients: A randomized control pilot trial.

Rupinder Kaur, Reena Jairus, Meena Sudan

Abstract read
In one paragraph

Article in Canadian oncology nursing journal = Revue canadienne de nursing oncologique, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Rupinder KaurAssociate Professor, {Secretary; Oncology Nurses Association of India (ONAI) Punjab Chapter, Membership number L/1202/14}, Fellowship in Palliative Care, PhD Scholar Department of Nursing, Sri Guru Ram Das University of Health Sciences Vallah, Amritsar, India.
Reena JairusDepartment of Nursing, Christian Medical College and Hospital, Ludhiana, India.
Meena SudanHead of Department, Department of Radiotherapy, Sri Guru Ram Das Rotary Cancer Hospital Vallah, Amritsar, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Chemotherapy-induced peripheral neuropathy (CIPN) is a dose-dependent, nerve-damaging adverse reaction with reported prevalence rates of 68.1% at the first month after starting chemotherapy; 60.0 % at the third month; and 30% at the sixth month. Purpose: To determine the effectiveness of an intervention (effleurage and petrissage) on severity of CIPN among patients receiving platinum-based chemotherapy. Methods: Sixty patients receiving either a third or fourth cycle of platinum-based chemotherapy were randomly assigned to one of two groups with a pre- and post-test design. The interventional group received effleurage and petrissage prior to chemotherapy for a period of one month. Comparisons of CIPN levels among both groups were done at Day 7, 14, 21, and 1 month using the FACT/ GOG-Ntx subscale. Results: Prior to intervention, the mean score (+SD) of CIPN in the intervention group was 17.17 (+4.907) and 17.10 (+ 4.421) in the control group (T = 0.055, P value 0.956). The post-test scores following intervention at 1 month, was a mean score (+SD) for CIPN in the intervention group of 10.70 (±2.855) and 16.27 (±3.039) in the control group (P value 0.000). Conclusions: This pilot result supports that the intervention (effleurage and petrissage) can be effective in reducing CIPN severity levels among patients receiving platinum-based chemotherapy.

Indexed as

chemotherapyeffleurageinducedneuropathyperipheralpetrissage

Identifiers

PMID39502102
PMCPMC11534368

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.